New Cardiovascular Warnings for Meridia (sibutramine hydrochloride)

New Cardiovascular Warnings for Meridia (sibutramine hydrochloride)
January 21, 2010
Audience: Cardiology and endocrinology healthcare professionals.

FDA notified healthcare professionals that the review of additional
data indicates an increased risk of heart attack and stroke in
patients with a history of cardiovascular disease using sibutramine.
Based on the serious nature of the review findings, FDA requested and
the manufacturer agreed to add a new contraindication to the
sibutramine drug label stating that sibutramine is not to be used in
patients with a history of cardiovascular...

--
Expo Controla Tu Peso, la primera expo para bajar de peso!
esgdivisionmedica.4t.com

AYUDA PARA HAITI:
http://esgdivisionmedica.4t.com/rich_text_1.html